-CNBC Interview
Pfizer, BioNTech Launch Omicron-Adapted COVID Shot-Flu Combination Vaccine Study
Pfizer Inc (NYSE:PFE) and its German partner BioNTech SE (NASDAQ:BNTX) have started an early-stage study to evaluate a combination vaccine targeting COVID-19…